Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00268307 · ClinicalTrials.gov registry record · Phase 1
Bone Marrow Stem Cell Infusion Following a Heart Attack
A Phase 1 study of Acute Myocardial Infarction, sponsored by Minneapolis Heart Institute Foundation.
- Completed
- Registry status
- Phase 1
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT00268307: Completed Phase 1 study of Acute Myocardial Infarction, sponsored by Minneapolis Heart Institute Foundation.
NCT00268307 is a Phase 1 study of Acute Myocardial Infarction that has completed, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 41 participants, below the 1,880-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00268307, a Phase 1 study of Acute Myocardial Infarction, has completed, sponsored by Minneapolis Heart Institute Foundation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine the safety of giving a patient's own bone marrow-derived stem cells delivered with a catheter (tube) into the coronary arteries (blood vessels of the heart). Stem cells are simple cells produced by the bone marrow that can develop into many types of cells. It is possible that these cells will decrease the size of damage caused to the heart from a heart attack and increase the pumping efficiency of the heart; which can be decreased due to a heart attack. The stem cells will be taken from bone marrow and then given back into the heart vessels.
Conditions Studied
Interventions
- DRUG Autologous, Unfractionated Bone Marrow Mononuclear Cells
Study Locations (1)
Minnesota
- Minneapolis Heart Institute Foundation - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2005-12 |
| Est. Completion | 2010-09 |
| Phase | Phase 1 |
What the finished NCT00268307 record still lists
NCT00268307 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,880-participant average among 19 other Acute Myocardial Infarction trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Acute Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which Autologous, Unfractionated Bone Marrow Mononuclear Cells is the first listed.
NCT00268307 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00268307 about?
NCT00268307 is a clinical study titled "Bone Marrow Stem Cell Infusion Following a Heart Attack". The goal of this study is to determine the safety of giving a patient's own bone marrow-derived stem cells delivered with a catheter (tube) into the coronary arteries (blood vessels of the heart). Stem cells are simple cells produced by the bone marrow that can develop into many types of cells. It i...
What is the current status of trial NCT00268307?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 41 participants. The study started on 2005-12. Estimated completion is 2010-09.
What conditions does trial NCT00268307 study?
This clinical trial studies the following conditions: Acute Myocardial Infarction.
What interventions are being tested in trial NCT00268307?
The interventions under investigation include: Autologous, Unfractionated Bone Marrow Mononuclear Cells (DRUG).
Who is sponsoring clinical trial NCT00268307?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00268307 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00268307's enrollment target sits among peer trials
41 19th of 19 higher than 1 of 19 other Acute Myocardial Infarction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Myocardial Infarction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
RECRUITING · NA
-
Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock
RECRUITING
-
Abbott Vascular Medical Device Registry
RECRUITING
-
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
RECRUITING · NA
-
Arrhythmia Detection After MI
RECRUITING · NA
-
COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia